US Patent Family Members and Approved Drugs for Canada Patent: 2096002
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: CA2096002
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,260,074 | 2040-03-30 | pancrelipase | Digestive Care, Inc. | PERTZYE |
| 5,324,514 | 2012-06-22 | pancrelipase | Digestive Care, Inc. | PERTZYE |
| 5,460,812 | 2012-06-22 | pancrelipase | Digestive Care, Inc. | PERTZYE |
| 5,578,304 | 2013-11-26 | pancrelipase | Digestive Care, Inc. | PERTZYE |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
